TrialThe Journal of investigative dermatology2015

Suppression of T Cell Activation and Collagen Accumulation by an Anti-IFNAR1 mAb, Anifrolumab, in Adult Patients with Systemic Sclerosis.

Xiang Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.